Health CareHealth Care Providers
  • Price (USD)495.64
  • Today's Change0.42 / 0.08%
  • Shares traded26.71k
  • 1 Year change+19.91%
  • Beta0.7826
Data delayed at least 15 minutes, as of Aug 17 2022 15:17 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Humana Inc. is a health and well-being company. The Company operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. It also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.

  • Revenue in USD (TTM)89.38bn
  • Net income in USD3.14bn
  • Incorporated1964
  • Employees95.50k
  • Location
    Humana Inc500 W Main StLOUISVILLE 40202United StatesUSA
  • Phone+1 (502) 580-1000
  • Fax+1 (302) 636-5454
  • Websitehttp://www.humana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HUM:NYQ since
Inclusa IncAnnounced12 Aug 202212 Aug 2022Announced2.39%--
Data delayed at least 15 minutes, as of Aug 17 2022 15:17 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Quest Diagnostics Inc10.58bn1.48bn16.23bn40.00k11.732.578.671.5512.0212.0286.3854.790.808634.168.31264,550.0011.299.4112.9510.9137.7137.5613.9613.221.4214.780.379125.1514.327.5039.5125.366.588.90
Molina Healthcare, Inc.30.27bn752.00m19.00bn14.00k25.696.7621.220.632912.8312.83516.3848.792.62--14.782,162,357.006.515.5514.7912.9314.6215.862.482.25--10.480.4580.0042.989.33-2.0866.18-15.24--
Laboratory Corp. of America Holdings15.72bn1.99bn22.86bn75.50k12.402.278.721.4920.8920.89165.38114.290.7724.725.34208,148.309.767.2511.238.4232.5631.7512.6810.121.7426.520.3436--15.3311.0352.7727.2810.54--
Centene Corp138.10bn1.86bn54.97bn72.50k30.162.1016.170.39833.143.14234.4045.241.81----1,904,759.002.432.84--------1.341.43--6.360.41390.0013.3825.41-25.5019.2324.36--
HCA Healthcare Inc60.11bn6.51bn60.30bn204.00k10.42--6.081.0320.8020.80193.46-12.821.214.677.39294,632.3014.6810.9918.9614.2684.2083.5812.189.181.326.041.039.1614.017.2185.3019.205.32--
Humana Inc89.38bn3.14bn61.73bn95.50k19.833.9715.670.688124.5124.51697.73122.402.11----935,947.607.398.68--------3.513.92--9.440.460211.057.668.84-12.8936.7220.0919.27
Cigna Corp179.18bn5.48bn86.97bn73.70k17.121.9710.320.488816.7716.77548.51145.371.17----2,431,248.003.613.81--------3.094.17--7.090.42075.818.6934.43-36.5723.5120.14151.19
Data as of Aug 17 2022. Currency figures normalised to Humana Inc's reporting currency: US Dollar USD

Institutional shareholders

45.73%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202210.52m8.31%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 20228.79m6.95%
Wellington Management Co. LLPas of 31 Mar 20228.78m6.94%
BlackRock Fund Advisorsas of 30 Jun 20225.85m4.62%
SSgA Funds Management, Inc.as of 31 Mar 20225.66m4.47%
Fidelity Management & Research Co. LLCas of 30 Jun 20225.58m4.41%
Capital Research & Management Co. (Global Investors)as of 31 Mar 20224.16m3.29%
Capital Research & Management Co. (International Investors)as of 31 Mar 20223.35m2.65%
Harris Associates LPas of 31 Mar 20223.07m2.42%
Geode Capital Management LLCas of 30 Jun 20222.10m1.66%
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.